Tomas Jernberg

20.6k total citations · 7 hit papers
331 papers, 11.7k citations indexed

About

Tomas Jernberg is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Tomas Jernberg has authored 331 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 268 papers in Cardiology and Cardiovascular Medicine, 96 papers in Radiology, Nuclear Medicine and Imaging and 75 papers in Surgery. Recurrent topics in Tomas Jernberg's work include Acute Myocardial Infarction Research (171 papers), Cardiac Imaging and Diagnostics (96 papers) and Heart Failure Treatment and Management (67 papers). Tomas Jernberg is often cited by papers focused on Acute Myocardial Infarction Research (171 papers), Cardiac Imaging and Diagnostics (96 papers) and Heart Failure Treatment and Management (67 papers). Tomas Jernberg collaborates with scholars based in Sweden, United Kingdom and United States. Tomas Jernberg's co-authors include Bertil Lindahl, Lars Wallentin, Stefan James, Karolina Szummer, David Erlinge, Stefan Agewall, Per Venge, Kai M. Eggers, Tomasz Baron and Mats Stridsberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Tomas Jernberg

306 papers receiving 11.5k citations

Hit Papers

Cardiovascular risk in post-myocardial infarction patient... 2010 2026 2015 2020 2015 2010 2010 2017 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
    2015 594 citations Tomas Jernberg, Pål Hasvold et al. European Heart Journal profile →
  2. The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
    2010 570 citations Tomas Jernberg, Kristina Hambræus et al. Heart profile →
  3. Troponin elevation in coronary vs. non-coronary disease
    2010 456 citations Stefan Agewall, Tomas Jernberg et al. European Heart Journal profile →
  4. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease
    2017 309 citations Bertil Lindahl, Tomasz Baron et al. Circulation profile →
  5. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014
    2017 276 citations Karolina Szummer, Lars Wallentin et al. European Heart Journal profile →
  6. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
    2024 99 citations Troels Yndigegn, Bertil Lindahl et al. profile →
  7. Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
    2025 14 citations Margrét Leósdóttir, Jessica Schubert et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Jernberg Sweden 55 8.9k 3.1k 2.9k 922 872 331 11.7k
Stefan Agewall Norway 46 6.1k 0.7× 2.8k 0.9× 2.0k 0.7× 1.0k 1.1× 804 0.9× 228 10.9k
Bertil Lindahl Sweden 66 12.3k 1.4× 4.1k 1.3× 5.2k 1.8× 950 1.0× 1.5k 1.8× 374 16.7k
Susan J. Zieman United States 35 6.5k 0.7× 2.1k 0.7× 1.7k 0.6× 660 0.7× 800 0.9× 62 9.1k
Karen S. Pieper United States 60 11.9k 1.3× 4.1k 1.3× 3.1k 1.1× 1.5k 1.6× 1.3k 1.5× 250 15.5k
Jaap W. Deckers Netherlands 50 7.4k 0.8× 2.9k 0.9× 2.0k 0.7× 1.0k 1.1× 939 1.1× 201 10.7k
Michał Tendera Poland 58 15.1k 1.7× 4.7k 1.5× 3.2k 1.1× 1.3k 1.4× 950 1.1× 276 20.3k
Ryan J. Lennon United States 62 8.8k 1.0× 6.0k 1.9× 3.6k 1.2× 2.1k 2.3× 1.2k 1.4× 298 13.7k
Héctor Bueno Spain 59 9.9k 1.1× 3.0k 1.0× 2.2k 0.7× 999 1.1× 1.3k 1.5× 394 13.7k
Nicolas Danchin France 61 10.8k 1.2× 5.4k 1.7× 3.0k 1.0× 1.2k 1.2× 1.1k 1.2× 580 15.6k
Marcus Flather United Kingdom 58 13.3k 1.5× 5.6k 1.8× 3.1k 1.1× 1.6k 1.8× 1.3k 1.5× 238 16.8k

Countries citing papers authored by Tomas Jernberg

Since Specialization
Citations

This map shows the geographic impact of Tomas Jernberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Jernberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Jernberg more than expected).

Fields of papers citing papers by Tomas Jernberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Jernberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Jernberg. The network helps show where Tomas Jernberg may publish in the future.

Co-authorship network of co-authors of Tomas Jernberg

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Jernberg. A scholar is included among the top collaborators of Tomas Jernberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Jernberg. Tomas Jernberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofmann, Robin, Martin Jönsson, Aristomenis Manouras, et al.. (2025). The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction: a prespecified substudy of the REDUCE-AMI trial. European Heart Journal - Cardiovascular Imaging. 26(4). 620–627. 1 indexed citations
2.
Ni, Wenli, Massimo Stafoggia, Siqi Zhang, et al.. (2024). Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden. Journal of the American College of Cardiology. 84(13). 1149–1159. 5 indexed citations
3.
Redfors, Björn, Truls Råmunddal, Oskar Angerås, et al.. (2024). Importance of hospital and clinical factors for early mortality in Takotsubo syndrome: Insights from the Swedish Coronary Angiography and Angioplasty Registry. BMC Cardiovascular Disorders. 24(1). 359–359.
4.
Ömerovic, Elmir, Truls Råmunddal, Pétur Pétursson, et al.. (2024). Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry. European Heart Journal. 46(6). 518–531. 7 indexed citations
5.
Ma, Kun, et al.. (2023). Lower income is associated with non-persistence to statin treatment after a first myocardial infarction. European Heart Journal. 44(Supplement_2). 1 indexed citations
6.
Koul, Sasha, Elmir Ömerovic, John Andersson, et al.. (2023). Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry. European Heart Journal. 44(Supplement_2). 1 indexed citations
7.
Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2022). Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European Heart Journal - Cardiovascular Pharmacotherapy. 9(2). 192–197. 15 indexed citations
8.
Matthews, Anthony, Karolina Szummer, Issa J Dahabreh, et al.. (2021). Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention. Journal of the American Heart Association. 10(11). e020357–e020357. 18 indexed citations
9.
Jernberg, Tomas, et al.. (2021). Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 8(5). 483–491. 30 indexed citations
10.
Bäck, Maria, Margrét Leósdóttir, Emil Hagström, et al.. (2021). The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry). European Heart Journal - Quality of Care and Clinical Outcomes. 7(5). 431–437. 36 indexed citations
11.
Alfredsson, Joakim, Stefan James, David Erlinge, et al.. (2021). Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI. American Heart Journal. 237. 13–24. 2 indexed citations
12.
Ekberg, Sara, Tomas Jernberg, Karolina Szummer, et al.. (2021). Myocardial infarction in diffuse large B‐cell lymphoma patients – a population‐based matched cohort study. Journal of Internal Medicine. 290(5). 1048–1060. 10 indexed citations
13.
Pawelzik, Sven‐Christian, David Erlinge, Tomas Jernberg, et al.. (2020). Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction. American Heart Journal. 231. 105–109. 18 indexed citations
14.
Wallert, John, Claes Held, Ronnie Pingel, et al.. (2020). Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry. European Heart Journal Acute Cardiovascular Care. 10(4). 372–379. 14 indexed citations
15.
Edfors, Robert, Lars Lindhagen, Jonas Spaak, et al.. (2020). Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction. Journal of Internal Medicine. 288(5). 581–592. 8 indexed citations
16.
Schubert, Jessica, Bertil Lindahl, Håkan Melhus, et al.. (2020). Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. European Heart Journal. 42(3). 243–252. 109 indexed citations
17.
Nyström, Thomas, Stefan James, Bertil Lindahl, et al.. (2019). Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial. Diabetes Care. 42(11). 2032–2041. 5 indexed citations
18.
Edfors, Robert, Anders Sahlén, Karolina Szummer, et al.. (2018). Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Heart. 104(19). 1575–1582. 27 indexed citations
19.
Lindahl, Bertil, Tomasz Baron, David Erlinge, et al.. (2017). Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Circulation. 135(16). 1481–1489. 309 indexed citations breakdown →
20.
Varenhorst, Christoph, Saga Johansson, Pål Hasvold, et al.. (2016). Abstract 13206: Culprit and Non-Culprit Recurrent Ischemic Events in Post-Myocardial Infarction Patients: Data From SWEDEHEART. Circulation. 134(suppl_1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Agewall Breakdown of academic impact, for papers by Bertil Lindahl Breakdown of academic impact, for papers by Susan J. Zieman Breakdown of academic impact, for papers by Karen S. Pieper Breakdown of academic impact, for papers by Jaap W. Deckers Breakdown of academic impact, for papers by Michał Tendera Breakdown of academic impact, for papers by Ryan J. Lennon Breakdown of academic impact, for papers by Héctor Bueno Breakdown of academic impact, for papers by Nicolas Danchin Breakdown of academic impact, for papers by Marcus Flather
Rankless by CCL
2026